Turning science into business: Merging AI and RNA
Drug Discovery World
FEBRUARY 27, 2023
For RNA, we’ve seen its success with Covid-19 vaccines and the approval of the first-ever RNA-targeting small molecule, risdiplam, for treating spinal muscular atrophy (SMA). Do you have any therapeutic targets in mind for your first small molecule drug candidate? Is there anything currently in the pipeline?
Let's personalize your content